By otakuyassine3@gmail.com 
Mutual of America Capital Management LLC lowered its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 2.3% in the fourth quarter, HoldingsChannel reports. The fund owned 31,788 shares of the health services provider’s stock after selling 736 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Maximus were worth $2,373,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of MMS. UMB Bank n.a. increased its position in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank purchased a new stake in shares of Maximus during the 4th quarter valued at $29,000. V Square Quantitative Management LLC increased its holdings in shares of Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after buying an additional 180 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Maximus during the 4th quarter worth $54,000. Finally, IFP Advisors Inc boosted its holdings in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after acquiring an additional 302 shares during the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Stock Performance
NYSE:MMS opened at $71.26 on Friday. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The firm has a market capitalization of $4.03 billion, a price-to-earnings ratio of 15.33 and a beta of 0.71. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm’s fifty day simple moving average is $72.80 and its 200 day simple moving average is $80.41.
Maximus (NYSE:MMS – Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, equities research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.68%. The ex-dividend date was Friday, February 14th. Maximus’s dividend payout ratio is presently 25.81%.
Wall Street Analyst Weigh In
MMS has been the subject of several research analyst reports. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research note on Thursday, January 2nd. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.
Check Out Our Latest Research Report on MMS
Insider Activity
In other Maximus news, Director Raymond B. Ruddy acquired 3,490 shares of the stock in a transaction on Thursday, December 12th. The stock was purchased at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the purchase, the director now directly owns 112,520 shares in the company, valued at $8,040,679.20. This trade represents a 3.20 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have bought 7,008 shares of company stock worth $497,835 over the last 90 days. Company insiders own 1.60% of the company’s stock.
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Maximus and related companies with MarketBeat.com’s FREE daily email newsletter.